All Articles

Review Article 
How to improve the precision of closed chest sublobar resections
Dominique Gossot, Rossella Potenza, Amaia Ojanguren, Agathe Seguin-Givelet
Precision Cancer Medicine  
2019,  
2:
14  
Review Article 
Disease progression in non-small cell lung cancer on immune-checkpoint inhibition, what are the options?
Rudolf M. Huber
Precision Cancer Medicine  
2019,  
2:
13  
Editorial Commentary 
Hanging in the balance: mitochondrial uncoupling protein-2 and the tumor microenvironment
Gyorgy Baffy
Precision Cancer Medicine  
2019,  
2:
12  
Review Article 
Planning and marking small nodules for surgery
Marcelo F. Jimenez, Marta G. Fuentes, Maria T. Gomez-Hernandez, Nuria M. Novoa
Precision Cancer Medicine  
2019,  
2:
11  
Review Article 
Prophylactic cranial irradiation (PCI) or magnetic resonance imaging (MRI) monitoring in limited small cell lung cancer: is it a question?
Paul Van Houtte, Martine Roelandts, Florian Charlier, Luigi Moretti, Dirk Van Gestel
Precision Cancer Medicine  
2019,  
2:
10  
Review Article 
Patient-tailored prevention of post-operative complications after lung resection
Elaine Teh, Gianluca Casali
Precision Cancer Medicine  
2019,  
2:
9  
Review Article 
Alternative non-homologous end joining repair: a master regulator of genomic instability in cancer
Daniele Caracciolo, Martina Montesano, Pierosandro Tagliaferri, Pierfrancesco Tassone
Precision Cancer Medicine  
2019,  
2:
8  
Editorial 
Access to the medicine market—we could do better!
Peter Kapitein
Precision Cancer Medicine  
2019,  
2:
7  
Editorial 
It’s all about diagnostics, stupid!
Piarella Peralta
Precision Cancer Medicine  
2019,  
2:
6  
Editorial 
Clinical outcomes provide new insights into transformation to small-cell lung cancer of pulmonary EGFR-mutant adenocarcinoma
Eric Santoni-Rugiu
Precision Cancer Medicine  
2019,  
2:
5  
Editorial 
Long non-coding RNA MALAT1 as metastasis suppressor
Sabrina Strano, Sara Donzelli, Giovanni Blandino
Precision Cancer Medicine  
2019,  
2:
4  
Mini-Review 
Guanine residues of precursor microRNA’s terminal loop as a potential target for cancer therapy and prevention
Amit Cohen, Mario Alberto Burgos-Aceves, Yoav Smith
Precision Cancer Medicine  
2019,  
2:
2  
Editorial 
4-1BB-mediated cancer immunotherapy: ‘mission impossible’ for non-engineered IgGs?
Luis Alvarez-Vallina
Precision Cancer Medicine  
2019,  
2:
1  
Editorial 
Liquid biopsy for tumor mutational burden predicts the effectiveness of atezolizumab in non-small cell lung cancer treatment
Takehiro Uemura, Toyoaki Hida
Precision Cancer Medicine  
2018,  
1:
21  
Meet the Professor 
Prof. Stephen M. Hahn: the important role of radiation oncology in precision oncology
Grace S. Li, Meiqing Yuan
Precision Cancer Medicine  
2018,  
1:
20  
Editorial 
Liquid biopsy-based biomarkers for early detection of pancreatic cancer
Johannes F. Fahrmann, Michela Capello, Samir Hanash
Precision Cancer Medicine  
2018,  
1:
19  
Editorial 
A step forward in the management of a rare disease, the anaplastic lymphoma kinase-rearranged non-small cell lung cancer
Angelo Delmonte, Lucio Crinò
Precision Cancer Medicine  
2018,  
1:
18  
Meet the Professor 
Philippe Lambin: how advances in imaging impact precision radiation oncology?
Julia Wang
Precision Cancer Medicine  
2018,  
1:
17  
Mini-Review 
What is the best drug as a front-line treatment for EGFR activating mutation?
Hidetaka Uramoto
Precision Cancer Medicine  
2018,  
1:
16  
Meet the Professor 
Bhadrasain Vikram: future road of radiation—radiomics and genomics will play important roles
Gin Li
Precision Cancer Medicine  
2018,  
1:
15  
Editorial 
PLX51107, a promising novel bromodomain and extra-terminal inhibitor in chronic lymphoid leukemia treatment
Claes Wahlestedt, Ines Lohse
Precision Cancer Medicine  
2018,  
1:
14  
Editorial 
AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis
Precision Cancer Medicine  
2018,  
1:
13  
Editorial 
Fatty acids: from adipocytes to cancer cells
Hiu Yee Kwan
Precision Cancer Medicine  
2018,  
1:
12  
Meet the Professor 
Dr. Shankar Siva: combination of immunotherapy and stereotactic ablative radiotherapy may be a better choice for cancer patients
Gin Li
Precision Cancer Medicine  
2018,  
1:
11